3.
Sample | Item | Before inactivation | n | After inactivation | Coincidence rate (%) | κ | P | 95CI% | ||
Positive (+) | Gray zone (±) | Negative (-) | ||||||||
Serum | IgM | |||||||||
Positive (+) | 5 | 5 | 0 | 0 | ||||||
Gray zone (±) | 1 | 0 | 1 | 0 | 100.0 | 1.000 | < 0.001 | 0.000-0.000 | ||
Negative (-) | 15 | 0 | 0 | 15 | ||||||
IgG | ||||||||||
Positive (+) | 7 | 7 | 0 | 0 | ||||||
Gray zone (±) | 0 | 0 | 0 | 0 | 100.0 | 1.000 | < 0.001 | 0.000-0.000 | ||
Negative (-) | 14 | 0 | 0 | 14 | ||||||
Plasma | IgM | |||||||||
Positive (+) | 5 | 5 | 0 | 0 | ||||||
Gray zone (±) | 1 | 0 | 0 | 1 | 95.2 | 0.881 | < 0.001 | - | ||
Negative (-) | 15 | 0 | 0 | 15 | ||||||
IgG | ||||||||||
Positive (+) | 7 | 7 | 0 | 0 | ||||||
Gray zone (±) | 0 | 0 | 0 | 0 | 100.0 | 1.000 | < 0.001 | 0.000-0.000 | ||
Negative (-) | 14 | 0 | 0 | 14 |